The Vita Coco Company, Inc. (COCO) Guidance & Earnings Results
On 2026-10-22 The Vita Coco Company, Inc. raised guidance: "FY2026 net sales raised to $810-820M from $790-805M; Non-GAAP Adjusted EBITDA raised to $170-175M; gross margin…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
COCOThe Vita Coco Company, Inc.Follow COCO — free
—
Price chart with a free account
- Market cap
- 3.2B
- P/E TTM
- 28.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 22 Oct, in -2 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 22 Oct 26 | Raised | FY2026 net sales raised to $810-820M from $790-805M; Non-GAAP Adjusted EBITDA raised to $170-175M; gross margin ~40% · full year |
| 23 Jul 26 | Raised | FY26 net sales raised to $790-805M from $720-735M; FY26 Adjusted EBITDA raised to $154-161M; FY26 gross margin ~40% · full year |
| 29 Apr 26 | Raised | FY2026 net sales raised to $720M-$735M (from $680M-$700M), Adj. EBITDA $132M-$138M · full year |
| 18 Feb 26 | Raised | FY2026 net sales $680-700M (midpoint $690M, +13% YoY); Adjusted EBITDA $122-128M (midpoint $125M, +28% YoY) · full year |
| 29 Oct 25 | Raised | Net sales guidance raised to $580-$595M; Adjusted EBITDA guidance raised to $90-$95M · full year |
| 30 Jul 25 | Raised | FY25 net sales raised to $565-580M; gross margin ~36%; Adjusted EBITDA $86-92M · full year |
The Vita Coco Company, Inc. — questions
- What guidance did The Vita Coco Company, Inc. give?
- On 2026-10-22: "FY2026 net sales raised to $810-820M from $790-805M; Non-GAAP Adjusted EBITDA raised to $170-175M; gross margin ~40%"
- When does The Vita Coco Company, Inc. report earnings?
- The Vita Coco Company, Inc.'s next earnings report is expected on 2026-10-22.
Every figure on this page comes from The Vita Coco Company, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.